Leah L Zullig1, Linda L Sanders2, Steven Thomas3, Jamie N Brown4, Susanne Danus5, Felicia McCant5, Hayden B Bosworth6. 1. Center of Excellence for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, USA; Department of Medicine, Duke University, Durham, USA. 2. Department of Medicine, Duke University, Durham, USA. 3. Department of Biostatistics and Bioinformatics, Duke University, Durham, USA. 4. Investigational Drug Service, Durham Veterans Affairs Medical Center, Durham, USA. 5. Center of Excellence for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, USA. 6. Center of Excellence for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, USA; Department of Medicine, Duke University, Durham, USA; Departments of Psychiatry and School of Nursing, Duke University, Durham, USA. Electronic address: boswo001@mc.duke.edu.
Abstract
OBJECTIVE: Because hyperlipidemia is asymptomatic, many veterans affairs (VA) patients may not perceive it seriously. We assessed key Health Belief model concepts to describe patients' cholesterol-related health beliefs and examine associations between patient-level factors and desire to improve cholesterol control. METHODS: We used baseline data from an ongoing randomized clinical trial. Eligible patients were receiving care at the Durham VA and had CVD risk-total cholesterol levels >130 mg/dL and/or <80% medication adherence in the previous 12 months. A survey assessed patients' health beliefs about high cholesterol and self-reported medication adherence. Multivariable logistic regression examined whether there was an association between desire to control cholesterol and cholesterol status. RESULTS: Approximately 64% (n=155) of patients perceived high cholesterol as 'very serious'. In multivariable logistic regression analysis, patients who perceived high cholesterol as 'very serious' (OR 2. 26, p=0.032) and/or with high self-efficacy (OR 4.70, p<0.001) had increased odds of desiring cholesterol control. CONCLUSION: The factors most significantly associated with desire to improve cholesterol control were perceiving hyperlipidemia as 'very serious and self-efficacy for cholesterol control. PRACTICE IMPLICATION: Educating patients, with the goal of appropriately increasing their perceived risk of disease, is likely necessary to impact cholesterol control.
OBJECTIVE: Because hyperlipidemia is asymptomatic, many veterans affairs (VA) patients may not perceive it seriously. We assessed key Health Belief model concepts to describe patients' cholesterol-related health beliefs and examine associations between patient-level factors and desire to improve cholesterol control. METHODS: We used baseline data from an ongoing randomized clinical trial. Eligible patients were receiving care at the Durham VA and had CVD risk-total cholesterol levels >130 mg/dL and/or <80% medication adherence in the previous 12 months. A survey assessed patients' health beliefs about high cholesterol and self-reported medication adherence. Multivariable logistic regression examined whether there was an association between desire to control cholesterol and cholesterol status. RESULTS: Approximately 64% (n=155) of patients perceived high cholesterol as 'very serious'. In multivariable logistic regression analysis, patients who perceived high cholesterol as 'very serious' (OR 2. 26, p=0.032) and/or with high self-efficacy (OR 4.70, p<0.001) had increased odds of desiring cholesterol control. CONCLUSION: The factors most significantly associated with desire to improve cholesterol control were perceiving hyperlipidemia as 'very serious and self-efficacy for cholesterol control. PRACTICE IMPLICATION: Educating patients, with the goal of appropriately increasing their perceived risk of disease, is likely necessary to impact cholesterol control.
Authors: Darren A Dewalt; Nancy D Berkman; Stacey Sheridan; Kathleen N Lohr; Michael P Pignone Journal: J Gen Intern Med Date: 2004-12 Impact factor: 5.128
Authors: Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson Journal: J Am Coll Cardiol Date: 2013-11-12 Impact factor: 24.094
Authors: Nicole Schupf; Rosann Costa; Jose Luchsinger; Ming-Xin Tang; Joseph H Lee; Richard Mayeux Journal: J Am Geriatr Soc Date: 2005-02 Impact factor: 5.562
Authors: Su Golder; Davy Weissenbacher; Karen O'Connor; Sean Hennessy; Robert Gross; Graciela Gonzalez Hernandez Journal: Drug Saf Date: 2022-08-07 Impact factor: 5.228